Alpha 2.0
Login Register
» Articles » PMID: 34341711

The Role of SGLT2 Inhibitors in Vascular Aging

Overview
Journal Aging Dis
Specialty Geriatrics
Date 2021 Aug 3
PMID 34341711
Citations 18
Authors
Le Liu
Yu-Qing Ni
Jun-Kun Zhan
You-Shuo Liu
Affiliations
Soon will be listed here.
Abstract

Vascular aging is defined as organic and functional changes in blood vessels, in which decline in autophagy levels, DNA damage, MicroRNA (miRNA), oxidative stress, sirtuin, and apoptosis signal-regulated kinase 1 (ASK1) are integral thereto. With regard to vascular morphology, the increase in arterial stiffness, atherosclerosis, vascular calcification and high amyloid beta levels are closely related to vascular aging. Further closely related thereto, at the cellular level, is the aging of vascular endothelial cells (ECs) and vascular smooth muscle cells (VSMCs). Vascular aging seriously affects the health, economy and life of patients, but can be delayed by SGLT2 inhibitors through the improvement of vascular function. In the present article, a review is conducted of recent domestic and international progress in research on SGLT2 inhibitors,vascular aging and diseases related thereto, thereby providing theoretical support and guidance for further revealing the relationship between SGLT2 inhibitors and diseases related to vascular aging.

Citing Articles

Impact of sodium-glucose cotransporter-2 inhibitors on pulmonary vascular cell function and arterial remodeling.

Zhang J, Ye X, Liu X, Zhang H, Qiao Q World J Cardiol. 2025; 17(1):101491.

PMID: 39866213 PMC: 11755123. DOI: 10.4330/wjc.v17.i1.101491.

Skin Markers of Premature Ageing in Patients with COPD: Results Form COSYCONET.

Melzer T, Graf V, Kronseder A, Karrasch S, Kerschner M, Vogelmeier C J Clin Med. 2024; 13(22).

PMID: 39598116 PMC: 11595569. DOI: 10.3390/jcm13226972.

Dapagliflozin targets SGLT2/SIRT1 signaling to attenuate the osteogenic transdifferentiation of vascular smooth muscle cells.

Li L, Liu H, Chai Q, Wei J, Qin Y, Yang J Cell Mol Life Sci. 2024; 81(1):448.

PMID: 39520538 PMC: 11550308. DOI: 10.1007/s00018-024-05486-8.

Is Arterial Stiffness Interconnected with Cardiovascular Drug Prescription Patterns, Body Composition Parameters, and the Quality of Blood Pressure Regulation in Hypertensive Patients?.

Radic J, Vuckovic M, dogas H, Gelemanovic A, Belancic A, Radic M Biomedicines. 2024; 12(9).

PMID: 39335575 PMC: 11429216. DOI: 10.3390/biomedicines12092062.

Inhibition of the RXRA-PPARα-FABP4 signaling pathway alleviates vascular cellular aging by an SGLT2 inhibitor in an atherosclerotic mice model.

Zhang W, Wang L, Wang Y, Fang Y, Cao R, Fang Z Sci China Life Sci. 2024; 67(12):2678-2691.

PMID: 39225895 DOI: 10.1007/s11427-024-2602-7.

References
1.
Pescatore L, Gamarra L, Liberman M . Multifaceted Mechanisms of Vascular Calcification in Aging. Arterioscler Thromb Vasc Biol. 2019; 39(7):1307-1316. DOI: 10.1161/ATVBAHA.118.311576. View
2.
Stamatelopoulos K, Sibbing D, Rallidis L, Georgiopoulos G, Stakos D, Braun S . Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease. J Am Coll Cardiol. 2015; 65(9):904-16. DOI: 10.1016/j.jacc.2014.12.035. View
3.
Dimitriadis G, Nasiri-Ansari N, Agrogiannis G, Kostakis I, Randeva M, Nikiteas N . Empagliflozin improves primary haemodynamic parameters and attenuates the development of atherosclerosis in high fat diet fed APOE knockout mice. Mol Cell Endocrinol. 2019; 494:110487. DOI: 10.1016/j.mce.2019.110487. View
4.
Xu L, Nagata N, Nagashimada M, Zhuge F, Ni Y, Chen G . SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice. EBioMedicine. 2017; 20:137-149. PMC: 5478253. DOI: 10.1016/j.ebiom.2017.05.028. View
5.
Lim J, Perwick R, Li B, Donaldson P . Comparison of the expression and spatial localization of glucose transporters in the rat, bovine and human lens. Exp Eye Res. 2017; 161:193-204. DOI: 10.1016/j.exer.2017.06.012. View